Ashkon Software



ISIS - Isis Pharmaceuticals, Inc.

Isis Pharmaceuticals, Inc. logo Isis Pharmaceuticals, Inc. was a biopharmaceutical company that was focused on discovering and developing RNA-based therapeutics. The company was founded in 1989 and was based in Carlsbad, California.

Isis Pharmaceuticals had a unique approach to drug discovery and development that involved targeting specific messenger RNA (mRNA) sequences that are involved in disease processes. By inhibiting the production of disease-causing proteins, the company's drugs had the potential to treat a wide range of diseases.

The company had a number of drug candidates in various stages of development for diseases such as cancer, cardiovascular disease, and rare genetic disorders. One of its most promising drug candidates was Kynamro, which was approved by the FDA in 2013 for the treatment of homozygous familial hypercholesterolemia.

In 2015, Isis Pharmaceuticals changed its name to Ionis Pharmaceuticals, Inc. to better reflect its focus on developing drugs that target RNA. The company continues to be a leader in the field of RNA-targeted therapeutics and has a number of promising drugs in it




Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer